Celcuity Inc. announced that the FDA approved Revtorpyk (gedatolisib) for the treatment of patients with hormone receptor positive (“HR+”), human epidermal growth factor receptor 2 negative (“HER2-”), locally… read more.
Nearly one in four U.S. workers (24%) say they are currently in a job they want to quit but stay with their employer for the health insurance, according… read more.
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the American Enterprise Institute found that insurance denials of first attempts to… read more.
A new study published in JAMA has found that insurance formulary rejections of single-source branded drugs are common in the United States and often leave patients without timely… read more.
The National Institute for Health and Care Excellence (NICE) has issued thirteen Technology Appraisal decisions in June 2026, delivering nine positive recommendations, one updated recommendation, and two terminations…. read more.
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a further nineteen positive recommendations spanning oncology, neurology, infectious disease, dermatology, cardiovascular medicine, diabetes,… read more.
Around £45bn in NHS funding will be diverted from other NHS care by 2036 to pay more for new medicines under the UK-US trade deal agreed last December… read more.
Chile’s complementary set of policies targeting food products high in fat, salt and sugar plausibly reduces the risk of school age children being overweight or having obesity, finds… read more.
The EU drug watchdog, the European Medicines Agency (EMA), has given the green light for eight new medicines at its May meeting. This brings to 36 the number… read more.
The European Medicines Agency (EMA) has been nominated for the European Ombudsman Award for Good Administration. The Agency’s One Health Instagram account is shortlisted in the ‘Excellence in… read more.
The European Medicines Agency (EMA) has unveiled a new communications effort designed to inform evidence-based decision-making. Vaccine Essentials offers healthcare professionals accessible summaries of how the quality, safety… read more.
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ today. The… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
